Operationalizing Screening for Non-Small Cell Lung Cancer: An International Discussion - Episode 5
Experts discuss the recent landmark approval of a national lung cancer screening program in Germany for high-risk individuals. The program, based on the NELSON trial, will use low-dose CT scans for smokers and former smokers aged 50-75 who quit within the last 10 years.
The conversation then contrasts this with the United States, where screening has been available for years but suffers from disappointingly low uptake (e.g., ~6% in Ohio), primarily because it relies on primary care physicians to initiate the process. Both experts acknowledge the challenge of motivating eligible populations. They also highlight significant ancillary benefits of screening, including early detection of other conditions like COPD, heart disease, and other cancers, as well as providing a powerful visual tool to encourage smoking cessation.